Millipore Sigma Vibrant Logo

219478 Cdk4 Inhibitor III - CAS 265312-55-8 - Calbiochem

View This Product on Sigma-Aldrich
219478
価格&在庫状況を照会

概要

Replacement Information

主要スペック表

CAS #Empirical Formula
265312-55-8C₁₅H₁₂N₂O₂S

価格&在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
219478-5MGCN
在庫状況検索中…
現在国内在庫なし
現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      樹脂アンプル 5 mg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示 
      値引
      ()
       
      弊社照会
      Description
      OverviewA cell-permeable dioxobenzothiazole compound that acts a selective Cdk4 inhibitor (IC50 = 6.0 µM for Cdk4/D1 and > 200 µM for Cdk2/A). Exhibit better cytotoxic potential against cancer cells (IC50 = 0.61, 1.08, 0.30, and 1.21 µg/ml against A 549, Col 1, HL-60, and HepG2 tumor cells, respectively) than Cisplatin (Cat. No. 232120).
      Catalogue Number219478
      Brand Family Calbiochem®
      Synonyms5-(N-(4-Methylphenyl)amino)-2-methyl-4,7-dioxobenzothiazole, Ryuvidine
      References
      ReferencesRyu, C.K., et al. 2000. Bioorg. Med. Chem. Lett. 10, 461.
      Product Information
      CAS number265312-55-8
      ATP CompetitiveN
      FormBlack-purple solid
      Hill FormulaC₁₅H₁₂N₂O₂S
      Chemical formulaC₁₅H₁₂N₂O₂S
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetCdk4
      Primary Target IC<sub>50</sub>6.0 µM for Cdk4/D1 and > 200 µM for Cdk2/A
      Purity≥90% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      219478-5MGCN 04055977218558

      Documentation

      Cdk4 Inhibitor III - CAS 265312-55-8 - Calbiochem (M)SDS

      タイトル

      英語版製品安全データシート((M)SDS) 

      Cdk4 Inhibitor III - CAS 265312-55-8 - Calbiochem 試験成績書(CoA)

      タイトルロット番号
      219478

      参考資料

      参考資料の概要
      Ryu, C.K., et al. 2000. Bioorg. Med. Chem. Lett. 10, 461.
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision11-October-2013 JSW
      Synonyms5-(N-(4-Methylphenyl)amino)-2-methyl-4,7-dioxobenzothiazole, Ryuvidine
      DescriptionA cell-permeable dioxobenzothiazole compound that acts a selective Cdk4 inhibitor (IC50 = 6.0 µM for Cdk4/D1 and >200 µM for Cdk2/A). Exhibit better cytotoxic potential against cancer cells (IC50 = 0.61, 1.08, 0.30, and 1.21 µg/ml against A 549, Col 1, HL-60, and HepG2 tumor cells, respectively) than Cisplatin (Cat. No. 232120).
      FormBlack-purple solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number265312-55-8
      Chemical formulaC₁₅H₁₂N₂O₂S
      Structure formulaStructure formula
      Purity≥90% by HPLC
      SolubilityDMSO (10 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesRyu, C.K., et al. 2000. Bioorg. Med. Chem. Lett. 10, 461.